9 unchanged sentences
The information required to be disclosed by Item 201(d) of Regulation S-K, “Securities Authorized for Issuance Under Equity Compensation Plans,” is referenced under Item 12 of Part III of this Annual Report on Form 10-K.
−Removed: Corporate Performance Graph
−Removed: The following performance graph and related information shall not be deemed to be “soliciting material” or to be “filed” with the SEC, nor shall such information be incorporated by reference into any future filing under the Securities Act of 1933, as amended, except to the extent that we specifically incorporate it by reference into such filing.
−Removed: The following graph compares the performance of our Class A Common Stock to the Nasdaq U.S.
−Removed: Benchmark Index and to the Nasdaq Biotechnology Index from December 31, 2019 through December 31, 2024.
−Removed: The comparison assumes $100 was invested after the market closed on December 31, 2019 in our Class A Common Stock and in each of the presented indices, and it assumes reinvestment of dividends, if any.
−Removed: The stock price performance included in this graph is not necessarily indicative of future stock price performance.
−Removed: COMPARISON OF 5-YEAR CUMULATIVE TOTAL RETURN
−Removed: Among The Nasdaq U.S.
−Removed: Benchmark Index,
−Removed: the Nasdaq Biotechnology Index,
−Removed: and Ironwood Pharmaceuticals, Inc.
+Added: Performance Graph
+Added: We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended, and are not required to provide a performance graph.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.